RAAS Inhibitors May Cut Risk for Rupture in Brain Aneurysm
Rupture risk reduced compared to non-RAAS antihypertensive drugs even among patients with controlled hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.